2011
February 1, 2012
Roche receives FDA clearance for test to screen and diagnose chlamydia and gonorrhea infection in symptomatic and asymptomatic patients
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance to the cobas® CT/NG Test for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections in bo...
> more
 

Our goal is to partner with news reporters and provide relevant information that is of interest to various targeted audiences. For Corporate Related or Product Related Media Questions:

 +1-317-521-2000

 

   email

 

 Roche US News

January 26, 2012
Roche enters strategic alliance with Technoclone to expand reagent portfolio
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has entered into a strategic alliance...
> more

January 16, 2012
Roche and Indiana Blood Center Partner for High School Scholarship Program
INDIANAPOLIS (January 16, 2012) – Roche Diagnostics and Indiana Blood Center have teamed up to create a $70,000 scholarship program for seniors in 174...
> more

December 5, 2011
Roche, ChanTest collaborate for preclinical cardiac safety testing of drug
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has entered into a collaborative agreement with ChanTest Corporation, a leading ion channel...
> more

December 5, 2011
Roche acquires Verum Diagnostica GmbH as part of plan to develop comprehensive coagulation testing portfolio for diagnostic laboratories
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has signed an agreement under which it will acquire 100 percent of Verum Diagnostica GmbH, ...
> more

 Roche Global News
Retrieving Data